Oracle Cancer Trust and the Head & Neck Cancer Foundation, have announced their merger and the formation of a new organisation named Oracle Head & Neck Cancer UK.

Tamara Kahn, CEO of Oracle Cancer Trust, will continue as the inaugural CEO of the new organisation. Michelle Vickers, formerly CEO of the Head & Neck Cancer Foundation, will transition into the newly created role of chief awareness officer.

Kahn said: "This merger represents a pivotal milestone in our race to overcome the head and neck cancer crisis currently facing the UK. We want and need to bring about change to ultimately save and improve patients’ lives. Our board of trustees see common values and shared objectives – giving the ability to make the new combined organisation stronger. In addition, the scale of the head and neck cancer problem in the UK warrants a bigger voice. Together we believe we can increase awareness and help drive treatment innovations that ultimately uplift positive patient outcomes and care standards."

The new organisation will leverage its combined existing medical networks and research capabilities, to further propel advancements in diagnostics and medical treatments.

The merger has been completed with all business operations successfully transitioned to the new entity.

---